Japan Point of Care Diagnostics Market Report by Product Type, Platform, Prescription Mode, End User, and Region 2025-2033
일본의 POC 진단 시장 규모는 2024년 17억 달러로 추정됩니다. 향후 IMARC Group은 이 시장이 2033년까지 38억 달러에 달할 것으로 예상하며, 2025-2033년간 연평균 성장률(CAGR)은 9.2%를 나타낼 것으로 예측했습니다. 암, 당뇨병, 심혈관 질환과 같은 만성 질환의 유병률 증가, 지역 클리닉, 약국, 재택 환경에 대한 선호도 변화, 고령화 인구 증가 등이 시장을 이끄는 주요 요인으로 꼽힙니다.
본 보고서에서 다룬 주요 질문
- 일본의 POC 진단 시장은 지금까지 어떻게 발전해왔고 앞으로 어떻게 발전할 것인가?
- 코로나19가 일본 POC 진단 시장에 미친 영향은?
- 일본 POC 진단 시장의 제품 유형별 분석은?
- 일본 POC 진단 시장의 플랫폼별 현황은?
- 일본 POC 진단 시장의 처방 형태별 분석은?
- 일본 POC 진단 시장의 최종 사용자별 분석은?
- 일본 POC 진단 시장의 밸류체인에는 어떤 단계가 있는가?
- 일본 POC 진단의 주요 촉진요인과 과제는?
- 일본 POC 진단 시장의 구조와 주요 기업은?
- 일본 POC 진단 시장에서의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 일본의 POC 진단 시장 - 서론
제5장 일본의 POC 진단 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033년)
제6장 일본의 POC 진단 시장 : 제품 유형별 분석
- 혈당 모니터링 키트
- 심장 대사 모니터링 키트
- 임신 및 불임 검사 키트
- 감염증 검사 키트
- 콜레스테롤 검사 스트립
- 혈액검사 키트
- 기타
제7장 일본의 POC 진단 시장 : 플랫폼별 분석
- 측면 흐름 분석
- 딥 스틱
- 마이크로플루이딕스
- 분자진단
- 면역측정
제8장 일본의 POC 진단 시장 : 처방 모드별 분석
제9장 일본의 POC 진단 시장 : 최종사용자별 분석
제10장 일본의 POC 진단 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제11장 주요 기업 개요
제12장 일본의 POC 진단 시장 : 업계 분석
- 성장 촉진요인 및 억제요인과 기회
- Porter의 Five Forces 분석
- 밸류체인 분석
제13장 부록
LSH
Japan point of care diagnostics market size reached USD 1.7 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 3.8 Billion by 2033, exhibiting a growth rate (CAGR) of 9.2% during 2025-2033. The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, shifting preferences towards community clinics, pharmacies, and home settings, and the expanding aging population represent some of the key factors driving the market.
Point of care diagnostics (POCD) refers to medical tests conducted at or near the site of patient care, providing rapid results for immediate clinical decisions. It is user-friendly, requiring minimal training for healthcare professionals and encompasses a broad spectrum of tests for infectious diseases, chronic conditions, pregnancy, and various biomarkers. It enhances accessibility to medical testing, especially in resource-limited settings. It aids in preventing the spread of contagious diseases within communities or healthcare facilities. It reduces the need for multiple clinical visits, offering convenience and potentially lowering healthcare costs. It assists in managing and adjusting treatment plans based on real-time data. It is widely used in emergency medicine to quickly assess and diagnose critical conditions, such as cardiac events, sepsis, or respiratory distress.
Japan Point of Care Diagnostics Market Trends:
The increasing prevalence of chronic diseases like cancer, diabetes, and cardiovascular problems, coupled with this rising need for regular monitoring and immediate medical attention, represents one of the primary factors driving the demand for POCD in Japan. Additionally, the expanding aging population and the increasing hospitalization rates are facilitating the market growth. Along with this, rapid urbanization, changing lifestyles of individuals, and the rising risk of lifestyle-related diseases, such as obesity and hypertension, are driving the market in the country. POCD facilitates the timely monitoring and management of these conditions, leading to greater demand for POC testing devices. Apart from this, shifting preferences towards community clinics, pharmacies, and home settings are influencing the market positively. Moreover, governing authorities of the country are continuously focusing on the modernization of the healthcare sector, which is offering a favorable market outlook. They are implementing several initiatives and offering favorable reimbursement rates that encourage technological integration in healthcare services. Furthermore, the robust technology sector of Japan is actively engaged in miniaturization and automation, ensuring that POCDs meet the highest standards of reliability and usability. Along with this, rising collaborations between healthcare providers, diagnostic companies, and research institutions in Japan are creating a positive outlook for the market. These partnerships foster innovation and enable the development of tailored POC solutions for specific medical conditions. In addition, the rising shift towards preventive healthcare and early disease detection is bolstering the market growth. POC diagnostics empower individuals to monitor their health regularly, fostering a proactive approach to healthcare and reducing the burden on healthcare facilities. The growing awareness among the Japanese population about the importance of regular health check-ups is influencing the market positively.
Japan Point of Care Diagnostics Market Segmentation:
Product Type Insights:
- Blood-Glucose Monitoring Kit
- Cardio-Metabolic Monitoring Kit
- Pregnancy and Fertility Testing Kit
- Infectious Disease Testing Kit
- Cholesterol Test Strip
- Hematology Testing Kit
- Others
Platform Insights:
- Lateral Flow Assays
- Dipsticks
- Microfluidics
- Molecular Diagnostics
- Immunoassays
Prescription Mode Insights:
- Prescription-Based Testing
- OTC Testing
End User Insights:
- Professional Diagnostic Centers
- Home Care
- Research Laboratories
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan point of care diagnostics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan point of care diagnostics market?
- What is the breakup of the Japan point of care diagnostics market on the basis of product type?
- What is the breakup of the Japan point of care diagnostics market on the basis of platform?
- What is the breakup of the Japan point of care diagnostics market on the basis of prescription mode?
- What is the breakup of the Japan point of care diagnostics market on the basis of end user?
- What are the various stages in the value chain of the Japan point of care diagnostics market?
- What are the key driving factors and challenges in the Japan point of care diagnostics?
- What is the structure of the Japan point of care diagnostics market and who are the key players?
- What is the degree of competition in the Japan point of care diagnostics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Point of Care Diagnostics Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Point of Care Diagnostics Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Point of Care Diagnostics Market - Breakup by Product Type
- 6.1 Blood-Glucose Monitoring Kit
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Cardio-Metabolic Monitoring Kit
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
- 6.3 Pregnancy and Fertility Testing Kit
- 6.3.1 Overview
- 6.3.2 Historical and Current Market Trends (2019-2024)
- 6.3.3 Market Forecast (2025-2033)
- 6.4 Infectious Disease Testing Kit
- 6.4.1 Overview
- 6.4.2 Historical and Current Market Trends (2019-2024)
- 6.4.3 Market Forecast (2025-2033)
- 6.5 Cholesterol Test Strip
- 6.5.1 Overview
- 6.5.2 Historical and Current Market Trends (2019-2024)
- 6.5.3 Market Forecast (2025-2033)
- 6.6 Hematology Testing Kit
- 6.6.1 Overview
- 6.6.2 Historical and Current Market Trends (2019-2024)
- 6.6.3 Market Forecast (2025-2033)
- 6.7 Others
- 6.7.1 Historical and Current Market Trends (2019-2024)
- 6.7.2 Market Forecast (2025-2033)
7 Japan Point of Care Diagnostics Market - Breakup by Platform
- 7.1 Lateral Flow Assays
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 Dipsticks
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
- 7.3 Microfluidics
- 7.3.1 Overview
- 7.3.2 Historical and Current Market Trends (2019-2024)
- 7.3.3 Market Forecast (2025-2033)
- 7.4 Molecular Diagnostics
- 7.4.1 Overview
- 7.4.2 Historical and Current Market Trends (2019-2024)
- 7.4.3 Market Forecast (2025-2033)
- 7.5 Immunoassays
- 7.5.1 Overview
- 7.5.2 Historical and Current Market Trends (2019-2024)
- 7.5.3 Market Forecast (2025-2033)
8 Japan Point of Care Diagnostics Market - Breakup by Prescription Mode
- 8.1 Prescription-Based Testing
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 OTC Testing
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
9 Japan Point of Care Diagnostics Market - Breakup by End User
- 9.1 Professional Diagnostic Centers
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Home Care
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Research Laboratories
- 9.3.1 Overview
- 9.3.2 Historical and Current Market Trends (2019-2024)
- 9.3.3 Market Forecast (2025-2033)
- 9.4 Others
- 9.4.1 Historical and Current Market Trends (2019-2024)
- 9.4.2 Market Forecast (2025-2033)
10 Japan Point of Care Diagnostics Market - Competitive Landscape
- 10.1 Overview
- 10.2 Market Structure
- 10.3 Market Player Positioning
- 10.4 Top Winning Strategies
- 10.5 Competitive Dashboard
- 10.6 Company Evaluation Quadrant
11 Profiles of Key Players
- 11.1 Company A
- 11.1.1 Business Overview
- 11.1.2 Product Portfolio
- 11.1.3 Business Strategies
- 11.1.4 SWOT Analysis
- 11.1.5 Major News and Events
- 11.2 Company B
- 11.2.1 Business Overview
- 11.2.2 Product Portfolio
- 11.2.3 Business Strategies
- 11.2.4 SWOT Analysis
- 11.2.5 Major News and Events
- 11.3 Company C
- 11.3.1 Business Overview
- 11.3.2 Product Portfolio
- 11.3.3 Business Strategies
- 11.3.4 SWOT Analysis
- 11.3.5 Major News and Events
- 11.4 Company D
- 11.4.1 Business Overview
- 11.4.2 Product Portfolio
- 11.4.3 Business Strategies
- 11.4.4 SWOT Analysis
- 11.4.5 Major News and Events
- 11.5 Company E
- 11.5.1 Business Overview
- 11.5.2 Product Portfolio
- 11.5.3 Business Strategies
- 11.5.4 SWOT Analysis
- 11.5.5 Major News and Events
12 Japan Point of Care Diagnostics Market - Industry Analysis
- 12.1 Drivers, Restraints, and Opportunities
- 12.1.1 Overview
- 12.1.2 Drivers
- 12.1.3 Restraints
- 12.1.4 Opportunities
- 12.2 Porters Five Forces Analysis
- 12.2.1 Overview
- 12.2.2 Bargaining Power of Buyers
- 12.2.3 Bargaining Power of Suppliers
- 12.2.4 Degree of Competition
- 12.2.5 Threat of New Entrants
- 12.2.6 Threat of Substitutes
- 12.3 Value Chain Analysis
13 Appendix
